• PurMinds signed a five-year collaboration with SpectroChip and Taiwan's Kaohsiung Municipal Siaogang Hospital to advance point-of-care diagnostic validation.
• The partners plan a joint clinical validation center to evaluate diagnostic performance and testing workflows, supporting SwiftLab platform commercialization.
• SpectroChip committed NT$3 million (about US$94,000) for hospital teaching and research over five years, generally NT$600,000 annually.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Purminds Enterprises Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: TO72907) on October 14, 2026, and is solely responsible for the information contained therein.